English English | 中文 中文

我們所有的期刊只有英語.

Oncology Signaling

Cancer signaling has become fundamental in our understanding and treatment of cancer. It will become essential in the development of precision medicine for cancer. Oncology Signaling welcomes the submission of research papers which investigates all aspects of signal transduction in oncology. This includes both basic science discovery and translational research.

Manuscripts detailing fundamental research on all aspects of oncology signaling will be considered. Papers describing the mechanisms of action of signaling pathways in cancer and how this relates to current treatments for cancer will be a focus. Potential research article topics include, but are not limited to:

  • Role of protein kinases
  • Lipid signaling
  • NO signaling and ion channels
  • Regulation of secondary messengers
  • Receptor functions
  • Guanine nucleotide regulatory proteins
  • Bioinformatic studies relevant to cell signaling
  • Micro-environmental signals
  • Anchor-scaffold signaling proteins
  • Targeted therapies
  • Chemotherapeutic drug mechanisms of action
  • Effects of signaling on the growth and differentiation of cancer cells

Authors should address the question of how their research results compare with previously reported studies. This could be in original research study or a relevant review of current advances in the oncology signaling. Short communications or research letters would also be acceptable. Manuscripts with emerging themes and ideas in oncology signaling will be encouraged to submit to this journal. The manuscripts should contain proper statistical treatment of the data. Relevant literature should be cited, including related publications by the authors.

View full aims and scope


Editor-in-Chief: Spencer Gibson
View full editorial board


Imprint: KeAi
ISSN: 2542-5633
Share this page: